On Friday, United Parcel Service, Inc. (NYSE:UPS)’s shares inclined 0.11% to $97.59.
UPS (UPS) declared that customers in the northern Netherlands will now be served out of a new 4,000 square-meter facility in Heerenveen. The new facility for package sorting and delivery employs 170 people, accommodates 55 delivery trucks and can sort 2,500 packages per hour. As the new center for UPS’s activities in the region, it is the base for providing reliable logistics and transport services to customers in Friesland, Groningen, Drenthe and the northeast region of the Flevoland province.
UPS drivers worldwide are among the safest on the roads, logging more than 4.8 billion kilometers per year and delivering more than 4 billion packages safely. Before ever making a delivery, all UPS drivers are taught safe driving methods through the company’s defensive driving platform and the training continues throughout their careers.
Steel Dynamics, Inc. (NASDAQ:STLD)’s shares dropped -2.04% to $19.17.
Steel Dynamics, Inc. (STLD) the company offered second quarter 2015 adjusted earnings guidance in the range of $0.20 to $0.24 per diluted share
Estimated second quarter adjusted earnings are higher than sequential first quarter 2015 adjusted earnings of $0.17 per diluted share and lower than prior-year second quarter earnings of $0.31 per diluted share. Counting the above items, earnings guidance for the second quarter 2015 is in the range of $0.11 to $0.15 per diluted share.
Profitability from the company’s steel operations for the second quarter 2015 is predictable to be similar in comparison to the sequential first quarter 2015 results. Improved second quarter 2015 shipments will be offset by unpredictable metal margin compression, driven by steel imports remaining much higher than originally anticipated, resulting in average quarterly steel prices decreasing more than average quarterly scrap prices. The benefit of reduced scrap pricing was realized in the second quarter; but, the continued flood of steel imports thus far in 2015 continued to pressure steel product pricing to a greater degree. However, steel pricing has recently begun to stabilize and domestic steel demand remains solid.
Continued demand for the company’s fabricated steel joist and decking products indicates the non-residential construction market is ongoing a positive trend. Second quarter 2015 profitability from the company’s fabrication operations is predictable to be higher than near-record sequential first quarter 2015 results.
Steel Dynamics, Inc., together with its auxiliaries, manufactures and sells steel products, processes and sells recycled ferrous and nonferrous metals, and fabricates and sells steel joist and decking products in the United States and internationally. The company operates in three segments: Steel Operations, Metals Recycling and Ferrous Resources Operations, and Steel Fabrication Operations. The Steel Operations segment provides a range of sheet steel products, such as hot roll, cold roll, and coated steel products; structural steel beams and pilings to construction market; various rail products for the railroad industry; rounds, round-cornered squares, and round engineered bars; angles, plain rounds, flats, channels, and billets; and merchant beams, channels, and specialty structural steel sections.
At the end of Friday’s trade, Axalta Coating Systems Ltd (NYSE:AXTA)‘s shares dipped -3.35% to $31.16.
Axalta Coating Systems Ltd. (AXTA) will host a conference call for its second quarter 2015 financial results at 8:00 a.m. EDT on Tuesday, August 4, 2015. Charles W. Shaver, Chairman and Chief Executive Officer, and Robert W. Bryant, Executive Vice President and Chief Financial Officer, will review the company’s financial performance for the period.
Axalta Coating Systems Ltd., through its auxiliaries, manufactures, markets, and distributes high performance coatings products primarily for the transportation industry. It operates through two segments, Performance Coatings and Transportation Coatings. The Performance Coatings segment offers various waterborne and solventborne products and systems that are used to refinish damaged vehicles for independent body shops, multi-shop operators, and original equipment manufacturer (OEM) dealership body shops.
AstraZeneca plc (ADR) (NYSE:AZN), ended its Friday’s trading session with -0.08% loss, and closed at $67.53.
AstraZeneca plc (ADR) (AZN) declared that the U.S. Food and Drug Administration (FDA) has approved IRESSA® (gefitinib) as a first-line treatment in patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.
IRESSA is a once daily oral EGFR-tyrosine kinase inhibitor (TKI), which inhibits the activity that contributes to intracellular signaling pathways implicated in the growth and survival of cancer cells. IRESSA was granted Orphan Drug Designation by the FDA in August 2014 for the treatment of EGFR mutation-positive advanced NSCLC.
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. Its principal products comprise Crestor for the treatment of dyslipidaemia and hypercholesterolemia; Seloken/Toprol-XL to control hypertension, and heart failure and angina; Onglyza for diabetes mellitus; Iressa for non-small cell lung cancer; Faslodex for breast cancer in post-menopausal women; and Zoladex for prostate cancer, breast cancer, and certain benign gynaecological disorders.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
